Rapt Therapeutics (RAPT) PT Lowered to $13 at Barclays
Tweet
Share
E-mailGet Alerts RAPT Hot Sheet
Price: $58.02 --0%
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Barclays analyst Leon Wang lowered the price target on Rapt Therapeutics (NASDAQ: RAPT) to $13.00 (from $35.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- Wedbush Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
- Braze Inc (BRZE) PT Raised to $40 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
